{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:15:58Z","timestamp":1786119358287,"version":"build-2736575974"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1097\/inf.0b013e3181a75939","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T11:41:23Z","timestamp":1256298083000},"page":"971-975","source":"Crossref","is-referenced-by-count":10,"title":["Cefepime and Mortality in Pediatric Acute Myelogenous Leukemia"],"prefix":"10.1097","volume":"28","author":[{"given":"Brian T.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Aplenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Localio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateri H.","family":"Leckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20210202","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jac\/dki448","article-title":"Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.","volume":"57","author":"Paul","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"R3-9-20210202","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(07)70109-3","article-title":"Efficacy and safety of cefepime: a systematic review and meta-analysis.","volume":"7","author":"Yahav","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R4-9-20210202","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1086\/339215","article-title":"2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.","volume":"34","author":"Hughes","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R5-9-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.leu.2403188","article-title":"Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.","volume":"18","author":"Lehrnbecher","year":"2004","journal-title":"Leukemia"},{"key":"R6-9-20210202","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/pbc.21613","article-title":"Infections in pediatric acute myeloid leukemia: lessons learned and unresolved questions.","volume":"51","author":"Sung","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"R7-9-20210202","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1182\/blood-2005-10-4004","article-title":"Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group.","volume":"108","author":"Aplenc","year":"2006","journal-title":"Blood"},{"key":"R8-9-20210202","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2307\/3109770","article-title":"Between- and within-cluster covariate effects in the analysis of clustered data.","volume":"54","author":"Neuhaus","year":"1998","journal-title":"Biometrics"},{"key":"R9-9-20210202","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/0003-4819-135-2-200107170-00012","article-title":"Adjustments for center in multicenter studies: an overview.","volume":"135","author":"Localio","year":"2001","journal-title":"Ann Intern Med"},{"key":"R10-9-20210202","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S1473-3099(08)70288-3","article-title":"Efficacy and safety of cefepime.","volume":"9","author":"Towne","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"R11-9-20210202","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2125.2000.00289.x","article-title":"Design issues for drug epidemiology.","volume":"50","author":"McMahon","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"R12-9-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1345\/aph.1D322","article-title":"Reversible coma secondary to cefepime neurotoxicity.","volume":"38","author":"Abanades","year":"2004","journal-title":"Ann Pharmacother"},{"key":"R13-9-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1517\/14740338.7.4.377","article-title":"The safety of cefepime in the treatment of infection.","volume":"7","author":"Drago","year":"2008","journal-title":"Expert Opin Drug Saf"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200911000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:06:29Z","timestamp":1786039589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200911000-00009"}},"subtitle":["A Retrospective Cohort Study"],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3181a75939","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}